Reduced numbers of circulating CD28-negative CD4+ cells in patients with rheumatoid arthritis chronically treated with abatacept

Int J Rheum Dis. 2013 Aug;16(4):469-71. doi: 10.1111/1756-185X.12056. Epub 2013 Apr 4.
No abstract available

Publication types

  • Controlled Clinical Trial
  • Letter

MeSH terms

  • Abatacept
  • Adult
  • Aged
  • Antirheumatic Agents / pharmacology
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / immunology
  • C-Reactive Protein / metabolism
  • CD28 Antigens / immunology*
  • CD4-Positive T-Lymphocytes / drug effects
  • CD4-Positive T-Lymphocytes / immunology*
  • Cell Count
  • Female
  • Humans
  • Immunoconjugates / pharmacology
  • Immunoconjugates / therapeutic use*
  • Male
  • Middle Aged
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Antirheumatic Agents
  • CD28 Antigens
  • Immunoconjugates
  • Abatacept
  • C-Reactive Protein